Anteris (AVR) Welcomes Two Directors as Major Trial Approaches

Anteris Technologies Global Corp. (NASDAQ:AVR) is one of the 11 Best New Penny Stocks to Buy Right Now. On June 9, Anteris Technologies Global Corp. (NASDAQ:AVR) announced that two new members, Mr. David Roberts and Mr. Gregory Moss, have joined its Board of Directors.

Mr. Gregory Moss is the Chief Business and Legal Officer, Corporate Secretary and Chief Compliance Officer at Evommune, Inc. On the other hand, Mr. David Roberts has been the President of LeMaitre Vascular, Inc. since 2007.

Anteris (AVR) Welcomes Two Directors as Major Trial Approaches

A scientist in a lab coat looking through a microscope, evaluating an advanced medical device.

The company welcomed Mr. Roberts and Mr. Moss as it prepares to start the pivotal clinical trial for the DurAVR THV global, called the PARADIGM Trial. The two new directors are highly accomplished healthcare executives based in the US, and they will help the company transition to its next phase of growth.

The PARADIGM study is scheduled for the third quarter of 2025. With the help of Mr. Roberts and Mr. Moss, Anteris Technologies Global Corp. (NASDAQ:AVR) aims to take this important step and move towards getting approval from the US and European regulators for the DurAVR THV for patients with aortic stenosis.

Anteris Technologies Global Corp. (NASDAQ:AVR) is a global structural heart company focused on designing, developing, and commercializing cutting-edge medical devices for cardiac care.

While we acknowledge the potential of AVR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than AVR and that has a 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 10 Best American Semiconductor Stocks to Buy Now and 11 Best Fintech Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.